Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertensioneye disorder, glaucoma, ocular hypertension, open-angle glaucomaRecruitingPhase 32026-06-23NCT07662759

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Kukje Pharma1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Kukje PharmaSeongnamSouth Korea1